NASDAQ VXRT: Is It The Right Time to Invest in Vaxart Stock?

Most of the investors are preferring to invest in stocks on vaccine making companies. There are many companies that are coming up with their own vaccine solution to fight Covid-19.

If you invest in a company with good potential, it will help you to magnify your earnings. While many people are investing in Pfizer and Modern stocks, there are other companies that are worth investing in.

Vaxart at https://www.webull.com/quote/nasdaq-vxrt is one such vaccine development company. This company has a different approach to fight Covid-19 as they are using actual pills instead of giving a vaccine jab.

What is Vaxart?

It is a biotechnology company that is moving forward in the race to develop a vaccine for fighting Covid-19. This company American company is known for discovering, developing and selling oral vaccine.

They are using pills that are temperature-stable and easily to ship. You don’t need to transport it using specialized refrigerators. Candidates don’t need to take an injection shot.

They can simply consume the pill without any administration and monitoring. Vaxart has already developed a tablet for the Influenza virus. Last year in the month of January, the company came with the idea to develop a similar tablet for Covid-19.

The tablet was tested in animals and showed positive results, which further encouraged them to boost the tablet development process.

Investing in Vaxart Stock:

Vaxart is doing quite well in the stock market. The stock prices are moving up and down between $6 and $8. However, in the month of February, the stock price went up to $23.

It shows that Vaxart is a good option for investment. There are many factors that make this stock better than others. Here are some of the reasons why you need to invest in NASDAQ VXRT.

  • Innovative Approach: While most of the companies are searching for a vaccine that can be given by injection, Vaxart has a different approach. They are developing tablets. The benefit of using a tablet is that anybody can take with without monitoring. It is easy to consume and easy to transport and store as well.
  • Vaccine Hesitators: Most people are hesitant to take vaccines under the preconceived notion that vaccines are bad. However, the same people are ready to take pills for the same. Vaccine hesitators can be a game-changer for Vaxart.
  • Competitive Advantage: Even though there are many competitors in the market, Vaxart enjoys a competitive advantage overall. They are going to start phase 2 of the clinical study for the pill by the second half of the year. If they are successful, it will boost NASDAQ VXRT price. So right now, when the price is low, it is a good opportunity to invest in the stock.

You can find more stocks such as nyse og at https://www.webull.com/quote/nyse-og for investing.